Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. GIVLAARI
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

GIVLAARI

Medicine - Posted on Apr 01 2021
Active substance (DCI)
  • givosiran
history (2)
  • 3/24/21

    GIVLAARI (givosiran)

    Mise à disposition en ville. Avis favorable au remboursement en ville uniquement pour les patients âgés de 18 ans et plus, a...
    CAV :
    54321
    icône flèche
  • Economic analysis
    6/24/20

    GIVLAARI

    First assessment. Favourable opinion for reimbursement only for patients aged 18 years and over with acute hepatic porphyria...
    CAV :
    54321
    icône flèche
Technical information
ATC code
  • A16AX16
Manufacturer
ALNYLAM FRANCE SAS
Presentation

GIVLAARI 189 mg/1 ml, solution injectable
1 flacon en verre de 1 ml (CIP : 34009 302 163 1 6)

All our publications
    Congenital, genetic and rare diseases Drug therapy Liver diseases Metabolic diseases Paediatrics

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
jyGuU2bN4WvPBh04